Galapagos NV
GLPG
$57.97
Share price
-1.46%
Change (1 day)
-24.71%
Change (1 year)
Market capitalization of Galapagos NV (GLPG)
Market cap: $3.85 Billion
As of May 2022 Galapagos NV has a market cap of $3.85 Billion. This makes Galapagos NV the world's 2642th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.
Market cap history of Galapagos NV from 2008 to 2022
| Year | Market cap | Change |
|---|---|---|
| 2022 | $3.88 B | 6.44% |
| 2021 | $3.65 B | -43.58% |
| 2020 | $6.47 B | -52.07% |
| 2019 | $13.50 B | 169.16% |
| 2018 | $5.01 B | 4.51% |
| 2017 | $4.80 B | 61.16% |
| 2016 | $2.97 B | 20.89% |
| 2015 | $2.46 B | 331.92% |
| 2014 | $0.57 B | -8.94% |
| 2013 | $0.62 B | 10.91% |
| 2012 | $0.56 B | 58.44% |
| 2011 | $0.35 B | -16.16% |
| 2010 | $0.42 B | 66.9% |
| 2009 | $0.25 B | 148.04% |
| 2008 | $0.10 B |
End of Day market cap according to different sources
On May 17th, 2022 the market cap of Galapagos NV was reported to be:
$3.80 Billion
$3.85 Billion
$3.81 Billion
$3.80 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $470.54 B | 12,118.39% | 🇺🇸 USA |
 Abbott Laboratories ABT | $200.55 B | 5,107.62% | 🇺🇸 USA |
 AbbVie ABBV | $273.51 B | 7,002.14% | 🇺🇸 USA |
 Sanofi SNY | $132.10 B | 3,330.37% | 🇫🇷 France |
 Merck MRK | $235.17 B | 6,006.75% | 🇺🇸 USA |
 Astrazeneca AZN | $203.41 B | 5,181.91% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $113.65 B | 2,851.14% | 🇬🇧 UK |
 Fortress Biotech
FBIO | $0.09 B | -97.47% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $9.32 B | 142.19% | 🇮🇱 Israel |